Obermatt
See Similar Stocks →

SNDL

NAQ:SNDL · CA83307B1013
PharmaceuticalsMedium

360

45
EV / EBIT1
Price / Owner Earnings97
Owner Earnings Yield1
Dividend Yield1
Price/Sales90
EV / Gross Profit67
Price/Book71
Return on Capital47
Cash Return on Capital52
Return on Equity52
EBIT Margin29
Gross Profitability43
Accruals72
Owner Earnings Margin51
Sales growth20
Profit growth21
Reinvestment59
Price momentum37
Debt load63
Refinancing90
Debt Payback1
Liquidity63
Analyst ratings42
Opinion Changes50
Price Target Upside86
Market mood29
Value Creation4/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

SNDL doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryCanada
IndustryPharmaceuticals
SizeMedium
TypePublic Company
ExchangeNASDAQCM
Founded2006
Employees418
Websitesndl.com
ISINCA83307B1013
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)
Themes
CannabisDistilleryAlternative MedicineMedicalOrganic

Description

SNDL Inc. engages in the production, distribution, and sale of cannabis products in Canada. The principal activities of the company are the retailing of wines, beers and spirits under the Wine and Beyond, Ace Liquor and Liquor Depot retail banners,…

Analysis

Middle-of-the-road

SNDL Inc. sits in the middle of our grid: average quality, average price, no obvious signal in either direction.

Valuation data is not available for this company.

Growth is moderate; the safety picture is adequate. The company scores 4/20 on our value-creation score: not creating value.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
71
2023202420252026

All-time high

88

Jan 2023

All-time low

67

Mar 2026

Average rank

73

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
90
83
91
70
Price/Earnings
1
14
37
7
Price/Book
71
81
82
72
Dividend Yield
1
1
1
1
Value (overall)
77
57
87
71

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare SNDL with its peers
OrganiGram Holdings
TOR:OGI
39
CountryCanada
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Trulieve Cannabis
CNX:TRUL
39
CountryUSA
IndustryPharmaceuticals
SizeMedium
Full Stock Analysis →
High Tide
CVE:HITI
62
CountryCanada
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Aurora Cannabis
TOR:ACB
34
CountryCanada
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Cronos Group
TOR:CRON
45
CountryCanada
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Canopy Growth
TOR:WEED
19
CountryCanada
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →